本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Elanco Animal Health Incorporated

21.32
0.0000
成交量:- -
成交額:- -
市值:85.02億
市盈率:118.44
高:21.32
開:21.32
低:21.32
收:21.32
52周最高:45.08
52周最低:17.98
股本:3.99億
流通股本:3.98億
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):0.1800
每股收益(LYR):0.1840
淨資產收益率:1.26%
總資產收益率:2.58%
市淨率:1.53
市盈率(LYR):115.86

資料載入中...

2023/07/14

重要事件披露

Form 8-K - Current report
2023/07/11

重要事件披露

Form 8-K - Current report
2023/05/22

重要事件披露

Form 8-K - Current report
2023/05/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

重要事件披露

8-K - Current report
2023/03/01

重要事件披露

8-K/A [Amend] - Current report
2023/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/21

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/01

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/01/31

重要事件披露

8-K - Current report
2023/01/09

重要事件披露

8-K - Current report
2022/12/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]